AaronMorrisEtraMD
Hematology • New York, NYClotting Disorder, Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor, Division of Hematology and Medical Oncology
Dr. Etra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 E 102nd St
New York, NY 10029Phone+1 212-241-6756
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2015 - 2018- Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2012 - 2015
Albert Einstein College of MedicineClass of 2012- Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Autologous Stem Cell Transplant for Crohn's Disease Start of enrollment: 2017 Jul 12
Roles: Contact, Principal Investigator, Sponsor-Investigator
Publications & Presentations
PubMed
- 13 citationsAssessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification.Aaron Etra, Stephanie Gergoudis, George Morales, Nikolaos Spyrou, Jay Shah
Blood Advances. 2022-06-28 - 136 citationsMAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHDHannah Major-Monfried, Anne S. Renteria, Attaphol Pawarode, Pavan Reddy, Francis Ayuk
Blood. 2018-06-21 - 9 citationsCurrent and Emerging Targeted Therapies for Acute Graft-Versus-Host DiseaseStelios Kasikis, Aaron Etra, John E. Levine
Biodrugs. 2021-01-01
Press Mentions
Itacitinib Appears Effective for Acute Graft-Versus-Host DiseaseFebruary 12th, 2023- Mount Sinai Researchers Find New, Safer Treatment for Serious Side Effect of Bone Marrow TransplantDecember 13th, 2022
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
